Biotech RadarJobs updated

COMPANY

Salvat

svt.com ↗

Clinical Phase 3

Profile checked Oct 10, 2026

Keywords: Otomycosis Cataract Acute Otitis Media Cataracts Infantile Acute Otitis Externa Pseudoarthrosis Otic Eczema Overactive Bladder DF289 DF277 SVT-15652 Clobetasol G238 SVT-40776

12Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population source ↗
  2. Trial start Phase 3: Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) source ↗
  3. Trial start Phase 3: SVT-15652 Otic Solution for the Treatment of Otomycosis. source ↗
  4. Trial start Phase 3: Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) source ↗
  5. Trial start Phase 3: SVT-15652 Otic Solution for the Treatment of Otomycosis source ↗
  6. Trial start Phase 3: Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa source ↗
  7. Trial start Phase 2: A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure) source ↗
  8. Trial start Phase 3: Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis source ↗
  9. Trial start Phase 3: Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema source ↗
  10. Trial start Phase 3: Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients source ↗
  11. Trial start Phase 3: Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients source ↗
  12. Trial start Phase 2: SVT-40776 in Patients Suffering From Overactive Bladder Syndrome source ↗

Clinical trials (lead sponsor) 12

RecordTitlePhaseStatusStartPrimary completion
NCT03686384SVT-15652 Otic Solution for the Treatment of OtomycosisPhase 3CompletedFeb 27, 2020Oct 25, 2021 (actual)
NCT05724446Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric PopulationPhase 3Unknown status (ClinicalTrials.gov)Dec 12, 2022Dec 31, 2025 (estimated)
NCT04246801Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)Phase 3CompletedJun 10, 2020May 19, 2021 (actual)
NCT04249076Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)Phase 3CompletedJun 4, 2020Apr 14, 2021 (actual)
NCT03686397SVT-15652 Otic Solution for the Treatment of Otomycosis.Phase 3CompletedJun 9, 2020Oct 19, 2021 (actual)
NCT03196973Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis ExternaPhase 3CompletedJul 22, 2017Aug 31, 2018 (actual)
NCT02483364A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure)Phase 2CompletedNov 10, 2015May 18, 2020 (actual)
NCT01404611Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric PatientsPhase 3Completed2011-062013-05 (actual)
NCT01996748Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic EczemaPhase 3Completed2012-022012-03 (actual)
NCT01993823Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of OtomycosisPhase 3Completed2013-052014-11 (actual)
NCT01395966Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric PatientsPhase 3Completed2011-062014-06 (actual)
NCT00507169SVT-40776 in Patients Suffering From Overactive Bladder SyndromePhase 2Completed2006-092007-09 (actual)
Feedback